Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverHYPR
HealthcareNGMUSD

Hyperfine, Inc.

$00123456789.0012345678900123456789+7.9%
52w low $0.75$2.22 52w high
Market data · updated 57m ago
Market data
Market cap
$95.35M
52w range
$0.75 - $2.22
Beta
1.40
Sector
Healthcare
Data quality
83/100
Valuation
fair value estimate
$0.38
Margin of safety
-56.4%
Quality & efficiency
Moat score
36/100
Return on equity
-89.8%
Profit margin
-226.9%
Debt / equity
0.39
Growth & analysts
Revenue growth
+82.6%
Analyst target
$2.17
Target upside
+148.5%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Hyperfine, Inc.

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Valuation

ValueGrowthProfitHealthIncome40QUALITY
Overall Rating
22
Very low quality
Very low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score36
Fair value estimate
$0.38-56.4% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$95.35M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+82.6%
Profit Margin
-226.9%
ROE
-89.8%
Debt / Equity
0.39
Beta
1.40
High GrowthBeaten Down

Statistics

Similar Stocks · Healthcare

Latest News · HYPR